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Abstract 
 Conventionally, cocaine is thought to exert its rewarding and reinforcing effects on the 
mesolimbic dopamine pathway, which is commonly referred to as the reward circuitry of the 
brain. Cocaine increases dopamine levels within the NAc by blocking dopamine reuptake by 
antagonizing dopamine transporters (DATs) on the VTA dopaminergic axon terminals. 
Traditionally, it is believed that with repeated cocaine use, this neuronal action causes 
neuroadaptations that underlie addiction. However, developments within the last two decades 
indicate that glial cells within the central nervous system’s immune system act as non-neuronal 
modulators of drug reward. It was recently found that cocaine interacts with the TLR4/MD-2 
complex to produce a proinflammatory response, and that this interaction is necessary for 
cocaine reward. The present investigation proceeds to demonstrate that cocaine can directly 
activate microglia cells through TLR4, causing them to upregulate mRNA of the 
proinflammatory cytokine, IL-1β, within the VTA. Furthermore, cocaine-induced dopamine 
increases in the NAc depend on cocaine-induced IL-1β signaling within the VTA.  TLR4 and IL-
1β are also important aspects underlying cocaine-primed reinstatement to drug seeking in a self-
administration paradigm. In this self-administration model, repeated exposure to cocaine 
appeared to induce glial priming, and led to the expression of additional proinflammatory 
markers throughout the mesolimbic dopamine pathway, providing new targets for further 
investigation into cocaine reinforcement. The investigation was expanded to include another 
commonly abused psychostimulant, methamphetamine (meth), which has also been recently 
shown to interact with the TLR4/MD-2 complex. Here, it is shown that the meth-induced 
neuroinflammation revealed within the mesolimbic dopamine pathway is TLR4 dependent; 
however, unlike cocaine, meth reward and reinforcement may be driven by mechanisms other 
than IL-1β signaling. Comparisons between cocaine-induced and meth-induced 
neuroinflammation suggest that IL-6 may also be an important molecule in mediating 
mesolimbic dopamine pathway functionality. The present studies provide evidence that the 
rewarding and reinforcing effects of psychostimulants arise from synergistic mechanisms 
involving both direct neuronal actions and neuroimmune interactions. 
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 1 
Introduction  
 Cocaine use is a prevalent societal issue throughout the world. Globally, between 14.25 
and 20.52 million people used cocaine in 2009 (UNODC 2011). An alarming 5.69 million of 
those users were in the United States, where 36% of the world’s cocaine supply was consumed 
(UNODC 2011). Fortunately, the number of Americans who reported using cocaine within the 
previous month decreased from 2.1 to 1.7 million from 2007 to 2012 (NIDA). Despite the 
decline, high rates of use among young adults, emergency room visits, and relapse make cocaine 
a predominant social, economic, and public health issue in the US. Many of those who use 
cocaine are at risk of addiction, jeopardizing their own health and overwhelming the health care 
system, as evidenced by the more than 420,000 cocaine related emergency room visits in 2009 
(SAMSHA, 2009). Arguably the most debilitating aspect of cocaine addiction is the high rate of 
relapse to cocaine use after recovery. One study in 2004 estimated the rate of relapse for cocaine 
addicts to be 61.9% (TEDS). 
 Successful treatment of cocaine addiction typically requires a variety of factors: a safe 
environment not associated with former drug use, healthy living conditions, proper social 
support, and some form of psychotherapy such as cognitive behavioral therapy (NIDA). Safe, 
healthy environments and social interaction are thought to act as natural rewards that stimulate 
the reward circuitry making drug-induced reward less appealing (Puhl, et. al. 2012). Social 
support and therapy is aimed at providing both the motivation to recover and the tools to resist 
the intense cravings and impulses that come with cocaine withdrawal (Winstanley et al., 2009). 
Unfortunately, not only do many afflicted individuals not have access to these aids, but even in 
ideal circumstances this treatment alone is largely ineffective. In fact, during withdrawal cocaine 
addicts often suffer from hindered motivation, self-control, and decision making that may lead to 
relapse before therapy can take effect (Goodman, 2008).  
 Changes brought on by chronic cocaine use drive these drug-seeking, impulsive 
behaviors characteristic of withdrawal due to the drug’s effect on the mesolimbic dopamine 
pathway, which serves as the reward circuitry of the brain. Any process that is essential to 
survival, such as eating and reproducing, results in an increase in extracellular dopamine in the 
nucleus accumbens (NAc) that instills a rewarding, euphoric affect to reinforce these behaviors 
(Ikemoto et al., 1999). The NAc receives dopaminergic projections from the ventral tegmental 
area (VTA), which also projects to the prefrontal cortex (PFC) (Wise, 1996 &1998). Behaviors 
that result in stimulation of this pathway are perceived as pleasurable, effectively creating a type 
of conditioned context and reward associative learning within this system (Hyman et al., 2006). 
Drugs of abuse, like cocaine, co-opt this system by manipulating dopamine signaling, thus 
leading to reward, or the euphoria that reinforces drug-taking behaviors. When studying drug 
addiction, measures of reward relate to the pleasure received from a drug while measures of 
reinforcement relate to tendency to repeat drug taking behaviors which is indicative of addiction. 
 Dopamine signaling in the NAc is regulated by a variety of mechanisms including 
GABAergic inhibitory connections in the VTA, dopamine metabolism in the synapse by 
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monoamine oxidase (MAO), and dopamine reuptake by dopamine transports (DAT) on VTA 
axon terminals (Spanagel & Weiss, 1999). These processes maintain a constant basal level of 
extracellular dopamine in the NAc. Cocaine’s primary mechanism of action is the direct 
antagonism of the dopamine transporters in the NAc (Ritz et. al., 1987; Volkow et. al., 1997). 
This causes extracellular dopamine levels to rise in the NAc (Chiara, 1988), which is associated 
with generating euphoria that, when paired to cocaine, produces the rewarding effect of the drug. 
As cocaine use persists, the elevated levels of dopamine in the NAc trigger neural adaptations 
that lower dopamine activity in an attempt to maintain homeostasis. One such adaptation 
involves the down-regulation of postsynaptic dopamine receptor expression (Volkow et. al., 
1990), resulting in decreased baseline dopamine signaling in the reward circuitry. This 
neuroadaptation is thought to underlie addiction, where inadequate dopamine signaling drives 
drug seeking in an effort to restore dopaminergic activity within the reward circuitry (Wise, 
1996). With repeated use, the brain developes a tolerance to the rewarding effects of a drug so 
that the addict transitions from liking the drug for its reward to compulsively wanting or needing 
it just to feel normal (Nestler el al., 1997). 
The cocaine addict, especially during abstinence, suffers from anhedonia and intense 
craving due to aberrant NAc activity and signaling (Koob & Moal, 1997). Meanwhile the PFC, 
although not implicated in cocaine reward, is highly involved in the development of other 
behaviors associated with addiction that make resisting drug cravings extremely difficult. 
Regions that are anatomically connected to the PFC limbic system, such as the ventral medial 
and orbitofrontal cortex, display altered functionality and activity in response to repeated cocaine 
exposure which drives the development of impulsivity and low self-control which worsen during 
withdrawal (Winstanley et al., 2009: Goldstein & Volkow, 2005). These behaviors, arising from 
aberrant PFC activity, increase susceptibility to addiction and relapse.  
 According to NIDA, there is currently no effective treatment for cocaine addiction. Due 
to the nature of this affliction, there are numerous sociological and psychological factors 
involved that make it extremely difficult to treat. Effective psychotherapy involves a community 
based “resocialization” aspect to support recovery. However, this leaves the patient susceptible 
to relapsing under the immense pressure from cocaine cravings once they leave the treatment 
program.  Psychotherapy is a promising treatment, yet on its own it is often unable to help 
addicts resist cravings that can last years. This is why NIDA considers an ideal treatment to be 
comprised of both psychotherapeutic and pharmacological components (NIDA). In order to 
combat the drug cravings associated with cocaine addiction, and therefore alleviate the strains 
the issue places on society and on the individual, a pharmacological intervention must be found.  
 
 
 
 
 
3 
Background  
 Historically, drug abuse research has focused on neuronal mechanisms in order to 
understand the neurobiology of reward and addiction and develop pharmacotherapeutic 
interventions. Unfortunately, no pharmaceutical intervention has yet proven to be an effective 
treatment. However, in recent decades, the role of non-neuronal cells in the central nervous 
system, particularly astrocytes and microglia, have earned attention for their contribution to a 
wide-range of disorders of the nervous system (Yong, 2010). Interestingly, microglia activation 
and the subsequent proinflammatory response has been shown to mediate both the initial 
rewarding effects of morphine as well as the development of a morphine tolerance (Hutchinson 
et. al., 2007; Watkins et. al., 2007).  
 Glial cells have long been well known for their traditional, supporting roles in the central 
nervous system including supplying nutrients and oxygen to neurons and removing dead neurons 
and related debris.  Astrocytes are traditionally understood to provide structural and metabolic 
support for neurons, help modulate the blood-brain barrier, and react to injury by secreting the 
intermediate filament protein GFAP to form glial scars, thus preventing aberrant connections 
from being made (Fawcett et al., 1999). Since 1994, when it was discovered that astrocytes 
participate in neuron signaling by releasing glutamate as well as by recycling neurotransmitters 
from the synapse (Parpura et. al., 1994), it has become clear that astrocytes should be considered 
a part of the brain signaling network. In fact, the term “tripartite synapse” was coined, indicating 
that astrocytes are an important element of a synapse because of their active role in modulating 
synaptic excitability (Volterra et. al., 2002). Microglia are an important part of the CNS’s 
immune system, where they function to detect and destroy pathogens as well as respond to tissue 
infection and injury. In their quiescent state, microglia constantly survey their environment. 
When they detect injury, invading pathogens, or other xenobiotics (foreign chemical substance 
not normally found in the organism), microglia will become activated and localize to the 
afflicted site to remove the bacteria, dead cells, or other debris. In an activated state, microglia 
will release a variety of proinflammatory molecules that initiate further glial activation of both 
microglia and astrocytes, as well as microglial migration in what is termed neuroinflammation 
(Hanisch & Kettenmann, 2007).  
 The proinflammatory cytokines released due to glia activation include interleukin-1beta 
(IL-1β), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNFα) (Watkins et. al., 2001). The 
existence of a glia-to-neuron signaling network is supported by research indicating that each of 
these proinflammatory cytokines is neuroexcitatory through numerous mechanisms (Stellwagen 
et. al., 2005; Vezzani & Viviani, 2014; Viviani et. al., 2003). Because drugs of abuse can be 
considered xenobiotics, investigation into the neuroimmune response to various drugs was 
initiated. In response to morphine, microglia cells become activated and release proinflammatory 
cytokines, a subset of which directly interact with receptors expressed on neurons (Schwarz et. 
al., 2013). An important cytokine involved in the proinflammatory cascade, IL-1β, has receptors 
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expressed on dopamine neurons that, when activated, can cause hyper-excitation of the cells (Ho 
& Blum, 1998; Long-Smith et. al., 2010). Furthermore, microglia can respond directly to 
dopamine release in the NAc (Schwarz et. al., 2013), which could perpetuate the neuroexcitatory 
effects of morphine-induced neuroinflammation.  
 These effects of morphine-induced glia activation could explain why microglia modulate 
the initial rewarding effects of morphine, measured by conditioned–place preference (CPP) and 
in vivo extracellular NAc dopamine quantification by microdialysis (Hutchinson et. al., 2007 & 
2012). Repeated administration of morphine further activates microglia, resulting in 
proinflammatory progressions that are responsible for developing both an opioid tolerance 
counteracting opioid analgesia, and an opioid dependence (Watkins et. al., 2007). Increased 
expression of the anti-inflammatory cytokine IL-10 in the NAc is shown to prevent reinstatement 
to morphine CPP, highlighting the role of neuroinflammation in opioid reward and reinforcement 
(Schwarz et. al., 2011). Furthermore, microglia activation inhibition by minocycline suppressed 
morphine-induced CPP (Hutchinson et. al., 2008), and glia activation inhibition by AV411 
attenuated morphine withdrawal symptoms in rats (Bland et. al., 2009).  
 Investigation into how morphine prompts glia activation revealed interesting results. 
Although microglia and astrocytes express classical opioid receptors, they can still become 
activated by morphine in classic opioid receptor knockout mice (Juni et. al., 2007), suggesting 
that morphine must activate glia by other means. One study revealed that glial activation by 
lipopolysaccharide (LPS) could suppress opioid analgesia, and that this effect could be blocked 
by (+)-opioid antagonists that have no binding affinity for the classic opioid receptors (Wu et. al., 
2006). The classic receptor for LPS, toll-like receptor-4 (TLR4), is found in the innate immune 
system and is preferentially expressed on microglia and astrocytes (Dauphinee et. al., 2006). 
Along with its soluble co-receptor MD-2, this pattern recognition receptor binds LPS (Shimazu 
et. al., 1999), which initiates a proinflammatory cascade involving activation of the 
proinflammatory transcription factor nuclear factor kappa-light-chain-enhancer of activated B 
cells (NFkB), leading to the production and release of proinflammatory cytokines such as IL-1β 
(Lee et. al., 2013). Further investigation into TLR4 mediated signaling demonstrated that 
morphine activates the TLR4/MD-2 complex, and that the selective TLR4 antagonist (+)-
naloxone suppresses behavioral and neurochemical measures associated with morphine reward 
and reinforcement (Hutchinson et. al., 2010 & 2012). Blocking morphine CPP and morphine-
induced extracellular dopamine increases in the NAc by TLR4 antagonism indicates that TLR4 
serves as a primary modulator of morphine reward and reinforcement (Hutchinson et. al., 2012). 
 Because morphine initiates a TLR4 dependent innate immune response that facilitates its 
rewarding, and possibly reinforcing effects, it was conjectured that other addictive drugs such as 
cocaine could utilize a similar mechanism to exert their rewarding and reinforcing effects since 
TLR4 is capable of recognizing a wide range of molecules. In fact, recent work using computer 
models has revealed that cocaine also interacts with the TLR4/MD-2 complex in silico 
(Northcutt et. al., 2015), suggesting that some of the effects of cocaine may be TLR4 mediated. 
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The influence of TLR4 activation on morphine reward prompts further investigation into the 
contribution of cocaine-induced/TLR4 activation underlying cocaine reward. It was found that 
both the blockade of TLR4 activation by (+)-naloxone and the blockade of microglia activation 
by minocycline could inhibit cocaine-induced CPP, a behavioral measure of reward (Northcutt 
et. al., 2015). This supported the prediction that TLR4 mediated neuroinflammation might serve 
an important role contributing to cocaine reward. Further investigation into the role of TLR4 in 
cocaine reward was assessed using microdialysis to measure extracellular dopamine signaling in 
the NAc. TLR4 blockade with (+)-naloxone and LPS-RS suppressed the cocaine-induced 
increase in extracellular NAc dopamine, further supporting the claim that TLR4 activation is 
necessary for cocaine to exert its rewarding effects (Northcutt et. al., 2015). Additionally, 
collaborative efforts with Bachtell et al., demonstrated the involvement of TLR4 signaling in a 
paradigm involving chronic exposure to cocaine: administration of the TLR4 antagonist, (+)-
naltrexone, dose-dependently suppressed cocaine-primed reinstatement to cocaine seeking in 
self-administering animals. 
 This thesis reviews my contribution to much of this recently published work as well as to 
the following investigations, as represented by the data presented in the following experiments. 
Seven total aims are included here, intended to further characterize the role of 
neuroinflammation in both cocaine reward and reinforcement: (1) to determine the effects of 
cocaine treatment on mRNA markers of proinflammatory activation in rapidly isolated microglia 
cells; (2)  to examine the proinflammatory response to a single cocaine injection within key 
regions in the mesolimbic dopamine pathway at different timepoints, achieving time and region 
specificity; (3) to examine the role of the key proinflammatory cytokine IL-1β in modulating 
dopamine signaling within the NAc, a well-supported neurochemical measure of cocaine reward 
and possible predictor of reinforcement; (4) to extend findings indicating TLR4 mediation of 
cocaine-primed reinstatement to cocaine seeking through examination of proinflammatory 
activation within the mesolimbic dopamine pathway; (5) to investigate the potential of cocaine-
induced microglial priming through examination of the proinflammatory response to a cocaine 
reinstatement challenge following saline or cocaine self-administration and extinction; (6) to 
establish which cell types express of TLR4/MD2 within key regions of the mesolimbic dopamine 
pathway and further explore microglia priming and reactivity in naïve, saline self-administering, 
and cocaine self-administering rats using immunohistochemistry; (7) to expand the investigation 
of TLR4-mediated neuroinflammatory responses underlying rewarding and reinforcing effects of 
drugs into meth by examining the proinflammatory response to acute meth administration. 
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Methods and Materials  
Subjects 
 Pathogen-free, adult male Sprague Dawley rats (Harlan Inc.) weighing approximately 
275-350 g were used for all rat studies at the University of Colorado at Boulder. Rats were pair-
housed in standard Plexiglas cages and provided with free choice food and water. The 
environment in the colony room was maintained at 21-23°C with a 12 hour light-dark cycle. 
Upon arrival, rats were allowed to acclimate for one week. All procedures were approved by the 
National Institute on Drug Abuse Intramural Research Program Institutional Animal Care and 
Use Committee. All studies were performed during the light phase.  
 
Drugs 
 Cocaine HCl was obtained from the National Institute on Drug Abuse (NIDA; Research 
Triangle Park, NC and Bethesda, MD, USA). Interleukin-1 receptor antagonist was purchased 
from Sigma (St Louis, MO, USA). Drugs were self-administered or given as ip injections in all 
studies as described below.  
Rapid Microglia Isolations 
Tissue Preparation  
 Rats were euthanized with a lethal i.p. injection of 65 mg/kg sodium pentobarbital 
(Abbott Laboratories, North Chicago, IL, USA) and transcardially perfused with ice cold 0.9% 
saline for 3 minutes. The brains were removed and diced with a scalpel on a glass petri dish over 
ice and placed, without the cerebellum, in a glass homogenizer containing 3 mLs 0.2% glucose 
in phosphate buffer saline (PBS). The tissue was gently and thoroughly homogenized before 
being filtered through a 70 μM filter into a 50 mL conical. The filter was then rinsed with 1 mL 
of PBS into the conical to collect the maximum number of cells possible. The filtrate was then 
pipetted into a 15 mL conical to be centrifuged at 350 x g for 10 minutes at RT. The supernatant 
was removed with a glass pipet and discarded.  
Density Gradient Microglia Isolation 
 Stock Percoll was diluted 1:10 in 10x (0.1M) PBS to make 100% isotonic percoll. 1x 
(0.01M) PBS was used to dilute the 100% percoll to 70% and 40% percoll. The pellet was 
resuspended and mixed in the room temperature 70% percoll. Next, 4 mLs 40% percoll was 
carefully layered onto the 70% percoll homogenate layer. Finally, 2 mLs 1x PBS was layered 
onto the 40% layer. Tubes were centrifuged at 1200 x g for 45 minutes at RT with minimal 
acceleration and no break. The density gradient centrifugation yielded two organic layers: the 
thicker, top layer within the 40% percoll and 1x PBS interface contained all CNS components 
minus microglia; the bottom, faint layer within the 40% and 70% percoll interface contained 
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isolated microglia cells. The top layer was carefully aspirated with a glass pipet without 
disturbing the microglia layer and discarded. The microglia cells were carefully aspirated from 
all conicals with a glass pipet and transferred into a single 50 mL conical where they were 
washed with 5 mL DPBS per brain. The cells were then centrifuged at 350 x g at RT for 10 
minutes with normal break and acceleration. Supernatant was pipetted away from the faint pellet 
and discarded.  
Microglia Plating and Treatment 
 The microglia pellet was immediately suspended in 5 mLs per brain DMEM 
(100 U ml−1 penicillin, 100 μg ml−1 streptomycin, 0.6%glucose and 2 mM L-glutamine) 
supplemented with 10% FBS. A hemocytometer was used to count stock cells so they could be 
diluted in DMEM/10% FBS media so that x cells could be plated in each of the 100 μl 96 V-
bottom wells. Cells were incubated for 24 h at 37 °C. Then, cell cultures were treated with 
various cocaine concentrations and incubated for 4 h at 37°C. After treatment, cells were 
centrifuged at 100 x g at 4°C for 10 minutes. After the supernatant was removed, the cells were 
removed with 100 μl Trizol and transferred to 1.5 mL microcentrifuge tubes to be processed for 
total mRNA extraction, cDNA synthesis, and PCR amplification as described below.  
Real Time RT-PCR 
Collection of Tissue Micro-punches  
 Two hours following acute drug injection (Experiment 2) or reinstatement challenge drug 
injection (Experiment 4,5), rats were euthanized with i.p. 65 mg/kg sodium pentobarbital (Abbott 
Laboratories, North Chicago, IL, USA) followed by transcardial perfusion with ice cold 0.9% 
saline. The brains were flash frozen in chilled isopentane, frozen on dry ice and stored at -80°C 
until the collection of tissue micro-punches. Brains were mounted on a cryostat and sectioned 
(30µm) at -20°C. The location of each region (VTA, NAc shell, vmPFC, BG) was determined 
using a brain atlas (Paxinos and Watson). Circular micro-punches of approximately 0.25 cm in 
length were taken from each region bilaterally using the blunt-end of 18-guage, stainless steel 
hypodermic tubing. Tissue micro-punches were stored in 1.5 ml microcentrifuge tubes, flash 
frozen in liquid nitrogen, and stored at -80°C until the mRNA extraction. Slices were taken near 
the beginning and end of each micro-punched section, mounted onto gel-treated slides, stained 
with cresyl violet, cover-slipped, and viewed under a light microscope to verify the accuracy of 
the micro-punch collection. 
Total RNA Extraction 
 Total RNA was isolated from each tissue micro-punch with the standard method of 
phenol:chloroform extraction (Chomczynski and Sacchi, 1987). Tissue micro-punches were first 
homogenized in 800 μl Trizol reagent (Invitrogen, Carlsbad, CA) for 30 seconds. For isolated 
microglia cells suspended in 100 μl Trizol,700 μl Trizol was added and cells were homogenized. 
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The samples were incubated for 5 minutes at room temperature before 160 μl of chloroform was 
added. Tubes were vortexed for 2 minutes followed by centrifugation (11,900 x g) for 15 
minutes at 4°C. The clear supernatant was pipetted out of the tubes without disturbing the 
aqueous, nucleic acid containing phase. 8 μl of Glycogen (Invitrogen) was added to bind the 
RNA and vortexed, followed by 400 μl of isopropyl alcohol which was added to facilitate 
nucleic acid precipitation. Samples were then briefly vortexed and incubated for 10 minutes at 
room temperature before centrifugation (11,900 x g) for 10 minutes at 4°C. The RNA pellet was 
washed twice in 1 ml 75% ethanol with centrifugation (7,500 x g) for 5 minutes at 4°C for each 
wash before being inverted and air dried for about 20 minutes. The pellet was finally 
resuspended in 11 μl nuclease free water and frozen at -80°C until cDNA synthesis.  
cDNA Synthesis  
 Extracted total RNA was reverse transcribed into cDNA using the SuperScript II First 
Strand Synthesis System for RT-PCR (Invitrogen). RNA samples were transferred to 1 ml 
microcentrifuge tubes and had 1 μl random hexamer primers (5 ng/μl) and 1 μl dNTPs (mM) 
added making the total reaction volume 13 μl. After a brief vortex and spin, samples were moved 
to the iCycler and incubated at 65°C for 5 minutes. Next, 4 μl of RT 5X buffer and 2 μl DTT 
(0.1M) was added to each tube, bringing the reaction volume to 19 μl, and incubated at 25°C for 
2 minutes. Finally, 1 μl of SuperScript III RT (200 U/μl) was added and the reaction was carried 
out at 25°C for 10 minutes then 42°C for 50 minutes. The reaction was inactivated at 70°C for 15 
minutes. The cDNA was diluted in 20 μl nuclease free water and stored at -20°C. 
 
Quantitative real time polymerase chain reaction (qRT-PCR) 
 PCR amplification of cDNA was performed using the Quantitect SYBR Green PCR Kit 
(Qiagen, Valencia, CA). Reactions were run in 96-well plates and the formation of PCR product 
was monitored in real time using the MyiQ Single-Color Real-Time PCR Detection System 
(BioRad, Hercules, CA). Each well contained 25 μl aliquots of a master mix containing (x, 
order?). For experimental cDNA samples, triplicate reactions were run so that 1 μl of each 
sample was added to three wells. PCR cycling conditions were as follows: 94°C for 15 minutes 
for Taq DNA polymerase hot-start activation; 40 cycles of denaturation at 95°C for 15s, 
annealing at 57°C for 30s, and extension at 72°C for 30s, at which temperature SYBR Green I 
fluorescence was captured. Relative gene expression was determined using the 2
-ΔΔ
CT method 
(Livak et al., 2001). Mean CT of triplicate measures was computed for each sample. Sample 
mean CT of the internal control (GAPDH) was subtracted from the sample mean CT of the 
respective gene of interest (ΔCT). The sample with the absolute highest mean ΔCT was selected 
as a calibrator and subtracted from the mean ΔCT of each experimental sample (ΔΔCT). 2-ΔΔCT 
yields fold change in gene expression of the gene of interest normalized to the internal control 
gene expression. A full outline of the total RNA extraction, cDNA synthesis, PCR amplification 
protocols, and primer sequences, can be found in prior publication (Frank et al., 2006). 
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Primer Specification 
 Primer sequences for mRNA of genes of interest expressed in glia and endothelial cells 
were designed by Dr. Matthew Frank at the University of Colorado at Boulder (Table 1). 
Table 1: 
Oligo Name Direction Oligo Sequence (5’ to 3’) 
GAPDH ei Forward TCTTCCAGGAGCGAGATCCC 
Reverse TTCAGGTGAGCCCCAGCCTT 
 
IL-1β ei Forward CCTTGTGCAAGTGTCTGAAG 
Reverse GGGCTTGGAAGCAATCCTTA 
 
IL-6 ei Forward AGAAAAGAGTTGTGCAATGGCA 
Reverse GGCAAATTTCCTGGTTATATCC 
 
TNFα ei Forward CAAGGAGGAGAAGTTCCCA 
Reverse TTGGTGGTTTGCTACGACG 
 
NFκBIA ei Forward CACCAACTACAACGGCCACA 
Reverse GCTCCTGAGCGTTGACATGA 
 
CD11B ei Forward CTGGTACATCGAGACTTCTC 
Reverse TTGGTCTCTGTCTGAGCCTT 
 
GFAP ei Forward AGATCCGAGAAACCAGCCTG 
Reverse CCTTAATGACCTCGCCATCC 
  
In-vivo Microdialysis 
Guide Cannula Placement Surgical Procedure 
 Each rat was anesthetized with isoflurane and placed in a stereotaxic apparatus. Sterile 12 
gauge CMA microdialysis guide cannula (CMA Microdialysis) were implanted into each rat 
aimed at the left or right nucleus accumbens shell (relative to bregma: Anterior/Posterior = +1.7 
mm; Medial/Lateral= ± 0.8 mm; relative to dura: Dorsal/Ventral= -5.6 mm, bite bar= 0) using a 
counterbalanced technique (Paxinos and Watson, 1998). For the purpose of intra-VTA injections, 
an injection guide cannula (Plastics One) was implanted into the VTA (relative to bregma: 
Anterior/Posterior = -5.0 Medial/Lateral= ± 0.9 mm; relative to dura: Dorsal/Ventral= -7.0 mm, 
bite bar= 0). Guide cannula and a tether screw (CMA Microdialysis) were attached to the skull 
using three jeweler’s screws and dental cement. Rats recovered for a minimum of one week 
before beginning in-vivo microdialysis.  
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Collection of Dialysate  
 On the afternoon preceding the microdialysis procedure, rats were transferred to the 
dialysis room that had the same light/dark cycle as the colony room. Rats were individually 
placed in Plexiglas bowls with ad libitum food and water. Once microdialysis probes (CMA 12, 
MW cut- off 20,000 Da, 2 mm active membrane) were inserted through each guide cannula, 
artificial cerebrospinal fluid (aCSF: 145 mM NaCl, 2.7 mM KCl, 1.2 mM CaCl, 1.0 mM KCl) 
was perfused through the probes at 0.2 μl/min overnight using a CMA infusion pump. In the 
morning on the day of the experiment the flow rate was turned up to 1.5 μl/min where it 
remained for the duration of the experiment. After the rats were allowed to acclimate to the 
higher flow rate for 2 hours, three baseline DA samples were collected. After the last baseline 
sample was collected, subjects began receiving injections. All samples were manually collected 
every 20 minutes for 4 hours (12 samples total) and stored at -80°C until HPLC analysis. 
Systemic Administration of Drugs  
All rats received two subcutaneous (s.c.) injections of either 2.5 mg kg−1 (+)-naloxone, 
for a total of 5 mg kg−1 (+)-naloxone, or equivolume saline. At 10 min following the first s.c. 
injection, rats received the second identical s.c. injection along with an intraperitoneal injection 
of either 10 mg kg−1 cocaine HCL or saline. 
VTA Microinjections 
  For studies requiring an intra-VTA microinjection, rats received 1 μl of drug (10 μg IL-1 
receptor antagonist in sterile saline) 10 min before an intraperitoneal administration of 
10 mg kg−1 cocaine or equivolume saline. 
High Performance Liquid Chromatography  
  A high performance liquid chromatography (HPLC) system was used to quantify 
dopamine concentrations within the NAc shell. The system consisted of an ESA 5600A 
Coularray detector with an ESA 5014B analytical cell and an ESA 5020 guard cell. The reverse 
phase liquid chromatography column was an ESA MD-150 (C-18, 3um, 150 x 3.2 mm), and the 
mobile phase was ESA buffer MD-TM (Chelmsford, MA, USA). The analytical cell potentials 
were kept at -100 mV and +250 mV and the guard cell at +300 mV. A standard curve of 
increasing dopamine concentrations was measured (0.5μL, 1μL, 2μL, 4μL, 8μL dopamine per 
27μL injection). Each dialysate sample was injected into the system, where the concentration of 
dopamine within each dialysate was determined by comparing the amount of dopamine separated 
in the column to the standard curve of dopamine concentrations. 
Microinjection Cannula and Microdialysis Probe Placement Verification 
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 Once the final dialysate sample was collected, rats were euthanized with i.p. 65 mg/kg 
sodium pentobarbital (Abbott Laboratories, North Chicago, IL, USA) to have their brains 
extracted. Brains were frozen in isopentane and sectioned (30 μm) on a cryostat at -20°C. Brain 
slices containing the VTA and NAc regions and cannula tracks were mounted onto gel-treated 
slides, stained with cresyl violet, cover-slipped, and viewed under a light microscope. To be 
included in the data analysis, 75% of the probe had to be within the NAc shell and 
microinjections had to be visibly within the VTA region.  
Self-Administration and Reinstatement 
Apparatus  
 Self-administration procedures were performed in operant conditioning chambers (Med-
Associates, St Albans, VT) equipped with two response levers and an infusion pump system.  
Procedure 
 Rats were first trained to press a level to acquire food pellets after 24-48 hours of food 
deprivation. This served to facilitate their acquisition of cocaine self-administration. Food pellets 
were received on a fixed ratio 5 (FR5) reinforcement schedule so that every 5 lever presses 
produced 1 food pellet. Training proceeded until the acquisition criteria of 30 food pellets 
produced within 3 consecutive sessions was met. Following acquisition training, rats were fed ad 
libitum for at least 1 day before undergoing jugular catheterization surgeries. For the 
reinstatement paradigm (Experiments 4, 5), rats self-administered saline, or cocaine as described 
below. They were then given s.c. injections of either saline or cocaine (15 mg/kg) as the 
reinstatement challenge in their home cages after lever responding was extinguished over 8 daily 
extinction sessions. 2 hours later, rates were euthanized, saline perfused, and their brain were 
removed for micro-punching and mRNA processing as described above. For Experiment 6, rats 
again acquired either saline or cocaine self-administration and underwent extinction training. 
However, rats received no reinstatement challenge and were sacrificed following the extinction 
training for immunohistochemistry as described below.  
Jugular Catheterization  
 Rats were implanted with intravenous jugular catheters under halothane anesthesia (1-
2.5%). The chronic indwelling catheters were implanted in the right jugular vein that exited the 
animal in the midscapular region. Following surgeries, rats were individually housed in the 
colony room and allowed to recover for one week.  
Cocaine Self-Administration 
 After a 1 week recovery from surgery, cocaine self-administration training was conducted 
in 15 2-h daily sessions at fixed ratio 1 reinforcement schedule with a cocaine dosage of 
0.5mg/kg/infusion. Cocaine injections, delivered over 5 s concurrent with the illumination of a 
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stimulus light above the active lever, followed by a 15-s timeout period when the house light 
remained off and responding produced no consequence. Responses on the second lever produced 
no consequence. The positions of active and inactive levers were counterbalanced. To assess a 
full range of cocaine doses in a single session, the final phase of training consisted of separating 
the session into five sequential 20 min components to deliver cocaine injections in an ascending 
order as follows: no injection (referred to as extinction), 0.03, 0.09, 0.27 and 0.89 mg kg−1 per 
injection, each preceded by a 2-min timeout period. A sample injection of cocaine at the 
corresponding dose occurred independently of responding at the end of each timeout. Training 
continued until: (1) a minimum of 5.0 mg kg−1 cocaine was self-administered within a session 
with <20%variation in the total number of injections compared with the previous session, (2) the 
dose of cocaine that maintained maximal response rates varied by no more than one-half log unit 
over two consecutive test sessions and (3) maximal response rates were at least fivefold higher 
than response rates maintained during extinction. 
Immunohistochemistry  
Collection of Tissue by Paraformaldehyde Perfusions  
 After undergoing saline/cocaine self-administration (Experiment 6), rats were euthanized 
with i.p. 65 mg/kg sodium pentobarbital (Abbott Laboratories, North Chicago, IL, USA). Upon 
the cessation of motor reflexes, the subjects underwent transcardial perfusions with ice cold 
0.9% heparinized saline for 2 minutes, followed by ice cold 4% paraformaldehyde (8% 
paraformaldehyde cut with 0.2M PB the day of perfusions, pH 7.4) for 3 minutes. The brains 
were pulled and post-fixed in 4% paraformaldehyde for 4 hours at 4°C before being moved into 
22% sucrose at 4°C.  
Collection of Tissue Slices 
 Five days later, and once all of the brains have sunk in the sucrose, the brains were ready 
to be sliced for tissue. Prior to mounting, the brains were placed in -30°C isopentane for 
approximately 80-90 seconds. In a cryostat at -20°C, 30 μm slices were taken of each brain 
region (approx. 30 for PFC, 60 for NAc and VTA) and mounted onto SuperFrost gel-subbed 
slides (Fisher ScientiWc, Pittsburgh, PA). The location of each region (vmPFC, VTA, NAc) was 
determined using a brain atlas (Paxinos and Watson). Slides were allowed to dry overnight, and 
were stored at 4°C until staining.  
Antibody Staining  
 Tissue sections underwent double immunofluorescence staining for microglial activation 
marker CD11B (OX42 labeling) and TLR4 binding partner MD-2. Slides were washed in 1x 
(0.01M) phosphate buffer saline (PBS) and 0.5% Triton X in PBS (PBS-T). The first and third 
washes were in PBS-T while the second was in PBS, all lasting 5 minutes with slight agitation. 
Tissue was blocked overnight in 2.5% donkey serum albumin (DSA) in PBS-T at 4°C (Frank et. 
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al., 2006). On day two the slides were washed as before but for 10 minutes at a time. Tissue was 
next incubated in 1/100 dilutions of rabbit anti-rat MD-2 and mouse anti-rat OX42 in 2% donkey 
serum (in PBS-T) for 24 hours at 4°C. The antibody solution was pipetted onto the slides and 
covered with parafilm in an airtight humidified container. Following incubation the tissue was 
washed and then incubated in 1/200 dilutions of each secondary (488 donkey anti-rabbit for MD-
2; 594 goat anti-mouse for OX42) in 2% normal donkey serum (in PBS-T) for 2 hours at RT. 
The secondary antibodies were protected from light during incubation. Finally, the tissue was 
washed 3 times for 5 minutes in PBS. The slides were then briefly dunked in dH2O to remove 
salts and immediately cover-slipped with hard-set Vectashield with DAPI. Tissue was stored at 
4°C in the dark until analysis.  
Statistics 
 GraphPad Prism Version 5 (San Diego, CA, USA) was used to calculate statistics and 
create graphs. The types of statistical analyses done were chosen based on experimental design. 
Bonferroni post hoc tests were used for one-way analysis of variance (ANOVA), two-way 
ANOVA, and repeated measures ANOVAs. Specifics regarding the types of analyses used are 
indicated in the figure keys. Data are presented as mean±s.e.m. Data collection and 
quantification was performed blinded whenever possible; final analyses were not performed 
blind to the conditions of the experiments. However, when possible, behavioral analyses and 
experiments were performed blind to the experimenter.  
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Results  
Experiment 1: Cocaine upregulates Interleukin-1β (IL-1β) mRNA in rapidly isolated 
microglia 
 Our laboratory has demonstrated that cocaine activates TLR4 and that blockade of 
cocaine-induced TLR4 signaling suppresses measures of cocaine reward (Northcutt et. al., 2015). 
TLR4 is known to be preferentially expressed on microglia cells (Dauphinee et al., 2006). In 
order to explore whether cocaine-induced TLR4 activation is microglial-dependent, the effects of 
cocaine on rapidly isolated microglial cells were assessed. As shown in Figure 1, 24 hour 
incubation in varying concentrations of cocaine produced upregulation of IL-1β mRNA.  LPS is 
an outer-membrane component of gram-negative bacteria that is well characterized as a TLR4 
agonist (Watkins et. al., 2001); therefore LPS treatment in a subset of the rapidly isolated 
microglia served as the positive control. As expected, both the 10 ng/mL and 1 ng/mL 
concentrations of LPS caused significant IL-1β mRNA upregulation (***p<0.001).  
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Figure 1: TLR4 activation by lipopolysaccharide (LPS) and cocaine induce upregulation of IL-1β mRNA 
in rapidly isolated microglia cells treated in culture for 24 hours. mRNA expression is relative to that of 
GAPDH; shown as % of media control. One way analysis of variance (ANOVA) revealed a significant 
effect of treatment (***p<0.001). Bonferroni multiple comparisons indicated significant IL-1β mRNA 
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upregulation from 10 ng/ml LPS, 1 ng/ml LPS, 100 μM cocaine (***p<0.001), and 10 μM cocaine 
(**p<0.01). Data are data are mean s.e.m., n=3-5/group. 
There was significant cocaine-induced IL-1β mRNA upregulation at 100 μM 
(***p<0.001) and 10 μM (**p<0.01) but not at 1-0.001 μM, indicating a dose-dependent effect. 
Previous work with cultured neonatal microglia showed IL-1β mRNA was significantly 
upregulated in response to 1 hour cocaine incubations at 0.1 and 1 μM (Bonferroni post hoc, 
**p<0.01) and the expected dose-dependent effects of LPS on IL-1β mRNA upregulated 
expression. Furthermore, this action was shown to be TLR4 dependent as microglia treated in 
culture for 1 hour with 1 or 0.1 μM cocaine along with the TLR4 antagonist (+)-naloxone at 1 or 
10 μM completely suppressed microglial upregulation of IL-1β mRNA (Northcutt et. al., 2015; 
Sup Figure 1). Together, this data indicate that cocaine causes TLR4 mediated microglia 
activation leading to the expression of IL-1β.  
Experiment 2: Acute cocaine-induced IL-1β mRNA upregulation is significant within the 
VTA 2 hours following systemic injection 
 After confirming microglia cell reactivity in relation to cocaine-induced upregulation of 
IL-1β mRNA, this inflammatory response was assessed in regions relevant to cocaine reward in 
the mesolimbic dopamine pathway. Rats were given cocaine injections (10 mg/kg, i.p.), 
euthanized, saline perfused, and had their brains extracted 30 minutes or 2 hours following the 
acute drug administration. mRNA extracted from micro-punches from the vmPFC, NAc, and 
VTA was converted to cDNA and amplified via RT-PCR. This served to obtain both regional 
and temporal specificity in the assessment of the cocaine-induced proinflammatory response. It 
was found that IL-1β mRNA is upregulated at 2 hours, but not 30 minutes, in the VTA 
(**p<0.01), but not in the NAc or vmPFC after acute cocaine administration (Figure 2). None of 
the other mRNAs tested (GFAP, TNFα, CD11B, and TLR4) showed significant upregulation. A 
follow-up study was conducted to assess whether cocaine-induced mRNA upregulation is TLR4-
dependent.  In a two-by-two design, rats were treated with either vehicle or the selective TLR4 
antagonist (+)-naloxone (2.5 mg/kg total in two s.c. injections, spaced 10 minutes apart, with the 
second injection paired with either cocaine (10mg/kg i.p.) or vehicle), and given either cocaine 
(10 mg/kg i.p.) or equivolume saline injections. mRNA expression was assessed at 30 minutes 
and 2 hours following injections. Once again, cocaine induced upregulation of IL-1β mRNA 
expression and treatment with (+)-naloxone blocked this effect at 30 minutes (*p<0.05) and 2 
hours (**p<0.01) (Northcutt et. al., 2015; Sup Figure 2).  
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Figure 2: Bonferroni multiple comparisons revealed that cocaine (10 mg/kg, intraperitoneal (i.p.)) 
induced upregulation of interleukin-1β (IL-1β) mRNA in the ventral tegmental area (VTA) (**p<0.01) 
but not in the nucleus accumbens (NAc) shell or ventral medial prefrontal cortex (vmPFC). Two-way 
analysis analysis of variance (ANOVA) revealed and effect of region (p=0.034) and time following 
cocaine injection (p=0.017); data are mean s.e.m., n=5-6/group. (Northcutt et. al., 2015). 
Experiment 3: Intra-VTA Interleukin-1 receptor antagonism (IL-1ra) prevents cocaine-
induced dopamine increase within the nucleus accumbens shell  
 Systemic blockade of TLR4 suppresses cocaine-induced increases of intra-NAc 
dopamine (Northcutt et al., 2015).  Due to the finding that IL-1β mRNA is selectively 
upregulated in the VTA after an acute cocaine administration, a microdialysis experiment was 
performed to assess the effects of cocaine-induced IL-1β signaling on the mesolimbic dopamine 
pathway. A microdialysis probe was implanted into the NAc shell and a microinjection guide 
cannula was implanted in the VTA. The microdialysis probe has a semi-permeable membrane 
that allows extracellular dopamine within the NAc shell to diffuse through the probe membrane 
along its concentration gradient allowing live DA samples to be collected in the aCSF fluid. 
Dopamine was quantified using high-performance liquid chromatography and analyzed by 
repeated measures two-way analysis of variance (ANOVA) with Bonferroni post hocs. 
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Following the collection of three baseline samples, rats received intra-VTA injections of 10 μg in 
1 μl IL-1 receptor antagonist (IL-1ra) or saline 10 minutes prior to cocaine injections (10 mg/kg 
i.p.) at time zero. Cocaine paired with intra-VTA saline resulted in significant increases in 
extracellular NAc shell dopamine at 40, 60, and 100 minutes (Bonferroni, **p<0.01 and 
****p<0.0001). Pretreatment with IL-1ra completely suppressed the cocaine-induced dopamine 
increase in the NAc shell (Figure 3) while IL-1ra treatment alone had no effect on NAc 
dopamine levels.   
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Figure 3: Cocaine-induced increases in extracellular nucleus accumbens (NAc) shell dopamine are 
dependent on interleukin-1β (IL-1β) signaling within the ventral tegmental area (VTA). Cocaine (10 
mg/kg, i.p.) produces elevated extracellular dopamine in the NAc that are significant at 40, 60, and 100 
min (Bonferroni, **p<0.01, ****p<0.0001) following drug administration. Intra-VTA interleukin-1 
receptor antagonist (IL-1ra) suppressed this effect. There were no differences between other treatment 
groups. Data are mean s.e.m., n=3-4/group. (Northcutt et. al., 2015).  
These findings suggest that cocaine-induced increases of dopamine within the NAc shell 
are IL-1β dependent, implicating a critical role for IL-1β signaling underlying the rewarding 
effects of cocaine. When taken with the mRNA data indicating that cocaine-induced IL-1β 
mRNA upregulation is TLR4 dependent, evidence suggests that TLR4 activation is an important 
component underlying cocaine-reward, providing a possible pharmacological target in further 
studies of cocaine reward. In fact, in vivo TLR4 blockade by either subcutaneous (+)-naloxone 
(2.5 mg/kg in two injections spaced 10 min) or LPS-RS (5 μg, intra-VTA) also blocked cocaine-
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induced NAc shell extracellular dopamine increases (Northcutt et. al., 2015: Sup Figure 3). It has 
been shown that IL-1ra, (+)-naloxone, and LPS-RS microinjected into the VTA did not interfere 
with non-TLR4 activation of dopaminergic signaling (Northcutt et. al., 2015), suggesting that 
TLR4/IL-1β signaling blockade do not interfere with dopaminergic neuron functioning. 
Up to this point, the microglial proinflammatory response to an acute cocaine 
administration has been fairly well characterized in the context of cocaine reward. The next steps 
of this investigation were aimed at characterizing cocaine-induced neuroinflammation in a more 
clinically relevant, chronic model of cocaine administration by utilizing self-administration and 
reinstatement paradigms.  
Experiment 4:  Cocaine-primed reinstatement to cocaine seeking in self-administering rats 
induces IL-1β mRNA upregulation in the VTA 2 hours following drug challenge.   
 Two important findings were described above: first, acute cocaine administration causes 
a significant, TLR4 dependent upregulation of IL-1β mRNA within the VTA 2 hours following 
injection; second, IL-1β signaling is crucial in generating the cocaine-induced spike in NAc shell 
dopamine signaling. This highlights the role of inflammation in mitigating cocaine reward, ; 
however, how these inflammatory processes might contribute to the reinforcing effects of 
chronic cocaine exposure is unknown.  Interestingly, a single systemic administration of (+)-
naltrexone just prior to a cocaine-primed reinstatement trial dose-dependently suppresses cocaine 
seeking in self-administering rats (Bachtell et. al., unpublished; Sup. Figure 4). Further 
investigation has revealed that intra-VTA microinjection of IL-1ra attenuates cocaine primed 
reinstatement (Bachtell et. al., unpublished; Sup. Figure 5). It is important to note that while 
intra-VTA IL-1ra significantly attenuated reinstatement to cocaine seeking (***p<0.001), lever 
responding was still approximately 45% that of responding for the untreated cocaine 
reinstatement group, whereas systemic TLR4 blockade suppressed lever pressing such that it was 
not significantly different from extinction trails, suggesting that some TLR4 mediated signaling 
other than IL-1β may also be involved in circumstances of chronic or repeated cocaine exposure.  
A follow-up study was conducted in order to examine the nueroinflammatory response 
within the mesolimbic dopamine pathway in cocaine self-administration and reinstatement 
model. Rats were subjected to cocaine in a self-administration/reinstatement paradigm in which 
cocaine was self-administered (0.5mg/kg/infusion) on a fixed ratio schedule 1 of reinforcement 
in 15 daily sessions. Lever responding was extinguished in 8 daily extinction sessions. Following 
successful extinction, rats were given a cocaine challenge (15mg/kg, ip.), that served as a 
reinstatement prime in the previous study. However, instead of undergoing a reinstatement lever-
press session, rats were euthanized and underwent saline transcardial perfusions 30 minutes and 
2 hours after challenge injections. mRNA was extracted from micro-punches of the vmPFC, 
NAc, and VTA, and was then used to make cDNA for qRT-PCR as described previously. The 
control group consisted of animals that self-administered saline and had a saline challenge, while 
a naïve group was included for comparison. 
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Figure 4: Interleukin-1β (IL-1β) mRNA is upregulated within the ventral tegmental area (VTA) in 
response to a cocaine reinstatement challenge. (a-d) A cocaine challenge (15 mg/kg, i.p.) was given to 
rats in home cages following cocaine self-administration (0.5mg/kg/infusion) on a fixed ratio 
schedule 1 (FR1) of reinforcement over 15 daily sessions and 8 daily extinction sessions. Control 
animals self-administered saline and received a saline challenge, and are represented by the grey 
saline bars. One-way analysis of variance (ANOVA) assessed effect of treatment, bonferroni 
post hoc multiple comparisons assessed differences across data sets; data are mean s.e.m., n=3-
6/group. 
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Figure 4 depicts cocaine-induced IL-1β and CD11B mRNA expression at 30 minutes and 
2 hours within the VTA and NAc shell in the self-administration and reinstatement model. One 
way ANOVA analysis revealed an effect of treatment type (including cocaine 2h vs 30 min) for 
IL-1β expression in the VTA (***p<0.001) while bonferroni post hoc multiple comparisons 
indicated a significant increase in ventral tegmental IL-1β mRNA expression at 2 hours 
(**p<0.01), but not 30 minutes. For CD11B or TNFα (data not shown) mRNA expression, there 
were neither significant upregulations nor significant differences between the two time points 
within the VTA (p>0.05). The same was true for IL-1β and CD11B in the NAc (p<0.05). 
Repeated cocaine exposure resulted in a 251% increase in IL-1β mRNA expression at 2 hours 
when compared to IL-1β mRNA expression of saline self-administering animals, and a 416% 
increase at 2 hours when compared to naïve animals (data not shown). This is in contrast to the 
150% increase in IL-1β mRNA expression at 2 hours (when compared to naïve animals) found in 
response to a single cocaine injection in Experiment 2. This suggests that repeated glia activation 
with cocaine may sensitize them have a more robust proinflammatory response to subsequent 
cocaine exposure.  
Experiment 5: Chronic cocaine self-administration primes glial proinflammatory response 
to a cocaine reinstatement challenge.   
 The data from experiment 4 suggested that two hours following the cocaine challenge 
would be the ideal timepoint to further assess site-specific markers of neuroinflammation in the 
cocaine reinstatement paradigm. Further, the increase in intra-VTA IL-1β mRNA following an 
acute cocaine administration was exaggerated in self-administrating rats when compared to naïve 
rats receiving a single cocaine injection. This suggests the possibility of priming: a phenomenon 
observed in glial cells where repeated activation eventually leads the microglia to assume a state 
where they are not fully quiescent and will display an over-exaggerated proinflammatory 
response to subsequent activating stimuli (Perry, Cunningham & Holmes, 2007). In order to 
further explore the possibility of repeated exposure to cocaine leading to a primed inflammatory 
response, a two-by-two reinstatement follow-up study was conducted. Animals either self-
administered cocaine or saline and, following extinction training, received either a saline or 
cocaine reinstatement challenge. Brains were removed, VTA, NAc, and vmPFC micro-punches 
were collected and processed for RT-PCR analysis as described in experiment 4. The mRNA 
expression of a variety of genes was assessed within the mesolimbic dopamine pathway 
following extinction and a reinstatement challenge in order to paint a more complete picture of 
the CNS’s inflammatory response to repeated cocaine exposure and reinstatement.  
 The data summarized in Figures 5-7 depicts the mRNA expression of certain markers of 
neuroinflammation across different brain regions. The first two columns represent mRNA 
expression in rats that underwent saline self-administration (striped bars) and were given either a 
saline challenge (first column) or a cocaine challenge (second column). The next two columns 
depict (solid bars) mRNA expression for cocaine self-administrating rats presented with a saline 
(third column) or cocaine challenge (fourth column). An unweighted means analysis two-way 
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ANOVA revealed the effects of the self-administration drug and reinstatement challenge drug on 
the results. Bonferroni post hoc multiple comparisons assessed the effects of the reinstatement 
challenge drug on results within self-administration groups. Results are compared to the % 
mRNA expression of the saline S-A/saline challenge groups.  
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Figure 5 VTA:  Chronic cocaine self-administration sensitizes microglia inflammatory response in the 
ventral tegmental area (VTA) to subsequent cocaine administration after extinction to drug seeking. (a-f) 
Two by two study consisted of a group of saline self-administering (S-A) rats and cocaine S-A rats (15 
2hr daily sessions, 15 mg/kg/infusion) that received a saline or cocaine reinstatement challenge (15 mg/kg 
i.p.) following extinction training (8 2hr daily sessions). mRNA expression % of saline S-A/saline (saline 
self-admin. with saline challenge) relative to % of GAPDH expression. (a) IL-1β mRNA expression: two-
way analysis of variance (ANOVA) revealed a S-A group difference (**p=0.0013). (b) IL-6 mRNA 
expression: two-way ANOVA revealed a S-A group difference (*p=0.023) and a reinstatement challenge 
difference (*p=0.034); bonferroni multiple comparisons revealed significance of cocaine S-A/cocaine 
(*p<0.05). (c) CD11B mRNA expression: two-way ANOVA revealed a significant interaction (*p=0.012) 
and a reinstatement challenge difference (**p=0.001); bonferroni multiple comparisons revealed 
significance of cocaine S-A/cocaine (**p<0.01). (d) NFκBIA mRNA expression: two-way ANOVA 
revealed a S-A group difference (*p=0.011). (e) GFAP mRNA expression: two-way ANOVA revealed a 
S-A group difference (*p=0.031). (f) TNFα mRNA expression: no significance to report. Data are 
mean s.e.m., n=3-6/group. 
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Figure 6 NAc: Acute and reinstated cocaine upregulates nucleus accumbens (NAc) IL-1β mRNA. (a-f) 
Two by two study consisted of a group of saline self-administering (S-A) rats and cocaine S-A rats (15 
2hr daily sessions, 15 mg/kg/infusion) that received a saline or cocaine reinstatement challenge (15 mg/kg 
i.p.) following extinction training (8 2hr daily sessions). mRNA expression % of saline S-A/saline (saline 
self-admin. with saline challenge) relative to % of GAPDH expression. (a) IL-1β mRNA expression: two-
way analysis of variance (ANOVA) revealed a S-A group difference (**p=0.0087) and a reinstatement 
challenge difference (***p=0.0003); bonferroni multiple comparisons revealed significance of the 
cocaine challenge in both groups (**p<0.01). (b-d) No significance to report. (e) GFAP mRNA 
expression: two-way ANOVA revealed a significant interaction (**p=0.0077). (f) TNFα mRNA 
expression: no significance to report. Data are mean s.e.m., n=3-6/group. 
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Figure 7 PFC: Cocaine self-administration (S-A) induces IL-1β mRNA upregulation; cocaine 
reinstatement induces NFκBIA mRNA upregulation in the ventral medial prefrontal cortex (vmPFC). (a-
f) Two by two study consisted of a group of saline self-administering (S-A) rats and cocaine S-A rats (15 
2hr daily sessions, 15 mg/kg/infusion) that received a saline or cocaine reinstatement challenge (15 mg/kg 
i.p.) following extinction training (8 2hr daily sessions). mRNA expression % of saline S-A/saline (saline 
self-admin. with saline challenge) relative to % of GAPDH expression. (a) IL-1β mRNA expression: two-
way analysis of variance (ANOVA) revealed a S-A group difference (****p<0.0001). (b-c) No 
significance to report. (d) NFκBIA mRNA expression: two-way ANOVA revealed a reinstatement 
challenge difference (*p=0.014) and a significant interaction (*p=0.019); bonferroni multiple 
comparisons revealed significance of cocaine S-A/cocaine (**p<0.01). (e-f) No significance to report. 
Data are mean s.e.m., n=3-6/group. 
 In the VTA, analyses revealed significant differences in mRNA expression between the 
self-administration (S-A) groups for IL-1β (**p<0.01), IL-6, NFKBIA, and GFAP (*p<0.05). 
Within the cocaine S-A groups, the cocaine challenge caused significant mRNA upregulation of 
IL-6 (*p<0.05) and CD11B (**p<0.01), with a trend toward significance for both cocaine 
challenge groups for IL-1β. The IL-1β mRNA expression (254.7% of % saline) in this region 
replicated that of IL-1β in the timecourse experiment (251.5% of % saline; Experiment 4). In the 
NAc shell, IL-1β mRNA was expressed in the cocaine S-A group significantly more than it was 
in the saline S-A group (**p<0.01), while the cocaine challenge within groups also caused 
significant IL-1β mRNA upregulation (**p<0.01) when compared to animals that received a 
saline challenge. Finally, in the vmPFC, the S-A group difference was extremely significant for 
IL-1β mRNA expression (****p<0.0001). Within group analysis also showed that the cocaine 
challenge in cocaine S-A rats caused an upregulation of NFκBIA mRNA (**p<0.01). From this 
study it can be concluded that chronic cocaine exposure leads to vastly more neuroinflammation 
than acute cocaine exposure within the mesolimbic dopamine pathway. Interestingly, mRNA 
expression of some neuroinflammatory markers appear to remain elevated in cocaine S-A 
animals that only received saline following the 8 day extinction period. The proinflammatory 
mRNA response in cocaine S-A animals was further exaggerated when they received a cocaine 
injection following extinction, which also yielded the expression of more neuroinflammatory 
markers than did a single administration of cocaine following saline S-A. These findings would 
indicate that repeated cocaine exposure does indeed prime glia, leading to prolonged 
inflammation and a more robust response to further activation.  
Experiment 6: IHC staining of CD11B and MD-2 within the PFC, NAc, and VTA 
 Experiment 5 revealed that the inflammatory response to chronic cocaine self-
administration was substantial yet varied greatly between the different brain regions examined. 
Additionally, it would appear that chronically administering cocaine sensitizes, or primes, 
microglia cells to have a more robust response to subsequent cocaine administration. An in-
progress immunohistochemistry fluorescence staining experiment aims to determine if this 
immune response variability and sensitization is due to differential activation of microglia cells 
and/or differences in expressed concentrations of TLR4-MD-2 complexes across the brain 
regions of interest. Brains from naïve, saline S-A, and cocaine S-A rats have been collected to 
 
 
28 
determine how chronic cocaine exposure may alter microglial activation states and localization. 
This will also reveal if MD-2 localizes primarily to microglia cells and how much of it is present 
within key mesolimbic dopamine regions. Slices of the PFC, NAc, and VTA were dual stained 
for the microglial activation marker, CD11B, and for MD-2 protein. CD11B serves to show both 
the presence and state of microglia cells. The MD-2 antibody was chosen due to the lack 
availability of an antibody that is selective for TLR4, paired with evidence that the presence of 
the MD-2 protein is necessary for cocaine to bind to TLR4 (Northcutt et al., 2015). Figure 8 
depicts CD11B staining within the NAc from a trail staining run on tissue from one naïve and 
one cocaine S-A rat. 
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Figure 8: Repeated cocaine exposure alters microglial morphology. Pictures are taken of the NAc shell 
under 40X magnification using green-tritsy channel for OX-42 594 to observe CD11B in the region. (a) 
CD11B staining in a naïve rat. Two examples of quiescent microglia are shown in A.1 and A.2. (b) 
CD11B staining of a cocaine S-A rat. At least two examples of either activated or primed microglia are 
shown in both B.1 and B.2. S-A brains were pulled 24 hours following the last S-A session. This 
preliminary work is assessed only qualitatively in this thesis.  
Experiment 7: CD11B, IL-6, TNFα, and GFAP mRNA is upregulated in the VTA in 
response to an acute meth injection 
 Previous work has revealed that other drugs of abuse such as morphine (Hutchinson et. 
al., 2010 & 2012) and meth (Northcutt et. al., in preparation) also interact with the TLR4/MD-2 
complex. Given that TLR4 signaling is necessary for both cocaine reward and reinforcement, 
there was substantial interest in exploring whether or not meth interacts with TLR4 to cause 
neuroinflammation. Meth, like cocaine, is a psychostimulant that acts on DATs to increase 
extracellular dopamine, the difference being that meth actually reverses the direction of 
dopamine through these transporters, rather than antagonizing them. Recently, our laboratory 
demonstrated that meth does interact with MD-2.  Further, we found that systemic TLR4 
antagonism with (+)-naloxone suppresses meth CPP (Sup. Figure. 6) and attenuates meth-
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induced extracellular NAc dopamine elevations (Northcutt et al., in preparation; Sup. Figure 7).  
These findings suggest that meth may also interact with TLR4 to initiate neuroinflammatory 
signaling within the mesolimbic dopamine pathway.  
Similar to the methods described in experiment 2, the mRNA expression of various 
neuroinflammatory markers was assessed in the dopamine pathway in response to acute meth 
administration at 30 minutes and 2 hours (Figure 9). Intriguingly, IL-1β mRNA was not 
upregulated in any region at any timepoint. In the VTA, CD11B mRNA expression was 
upregulated at both 30 minutes and 2 hours (*p<0.05) and TNFα mRNA expression was 
significant at 30 minutes (**p<0.01). Two effects not found in the acute cocaine studies 
presented here upregulation of IL-6 (*p<0.05 at 2h) and GFAP (**p<0.01 at 30 min; *p<0.05 at 
2h) mRNA. These findings, given that TLR4 antagonism attenuates both meth induced NAc 
dopamine increases and CPP, imply that some TLR-4 mediated signaling other than that of IL-1β 
may be responsible for this increase and, possibly, the rewarding affect of meth.  
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Figure 9: Acute morphine administration (dose, i.p.) induces inflammatory mRNA upregulation in the 
ventral tegmental area (VTA). (a) CD11B: Two-way analysis of variance (ANOVA) revealed a 
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significant effect of brain region (*p=0.016) while bonferroni multiple comparisons revealed significant 
upregulation in the VTA at 30 min and 2 hr (*p<0.05). (b) TNFα: Two-way ANOVA revealed a 
significant effect of brain region (*p=0.036) and time (**p=-.006) and an interaction (*p=0.032) while 
bonferroni multiple comparisons revealed significant upregulation in the VTA at 30 min (**p<0.01). (c) 
IL-6: Two-way ANOVA revealed a significant effect of brain region (*p=0.0173) while bonferroni 
multiple comparisons revealed significant upregulation in the VTA at 2 hr (*p<0.05). (d) GFAP: Two-
way ANOVA revealed a significant effect of brain region (***p=0.0001) and time (**p=-.0016) and an 
interaction (*p=0.014) while bonferroni multiple comparisons revealed significant upregulation in the 
VTA at 30 min (**p<0.01) and 2 hr (*p<0.05). Data are mean s.e.m., n=3-5/group. (Northcutt et. al., in 
preparation). 
 In a two-by-two follow-up study, it was explored if the meth-induced mRNA 
upregulation of proinflammatory markers found in Experiment 7 is indeed TLR4 mediated. For 
the data summarized in Figure 10, rats were given either a (+)-naloxone (15 mg/kg, i.p.) or saline 
pretreatment followed by either a meth (1 mg/kg, i.p.) or saline injection. Brains were removed 2 
hours following injections, and VTA micropunches were collected. It was again found that at 2 
hours, IL-6 (**p<0.01) and CD11B (*p<0.05) mRNA was significantly upregulated in response 
to meth with vehicle treatments. However, when there was a (+)-naloxone pretreatment, there 
were no differences in mRNA expression between rats receiving a meth or saline injection 
(p>0.05). This experiment demonstrates TLR4 mediation of meth-induced neuroinflammation, 
which provides insight into the mechanisms underlying the suppression of meth reward with (+)-
naloxone found in previous work (Sup Figures 6,7).   
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Figure 10: Meth-induced upregulation of CD11B and interleukin-6 (IL-6) mRNA in the ventral 
tegmental area (VTA) is TLR4 dependent. (a) CD11B: Two-way analysis of variance (ANOVA) revealed 
a significant effect of the meth treatment (*p=0.0336) while meth (1 mg/kg, i.p.) injected with the vehicle 
caused a significant upregulation of CD11B mRNA (*p<0.05) (Bonferroni post hocs). (b) IL-1β: Meth 
did not cause significant mRNA upregulation (p>0.05). (c) TNFα: Meth did not cause significant mRNA 
upregulation (p>0.05). (d) IL-6: Two-way ANOVA revealed a significant interaction (**p=0.0017), and a 
significant effect of meth (**p=0.0049) and (+)-naloxone (*p=0.015). Bonferroni post hocs revealed that 
(+)-naloxone (15 mg/kg, i.p.) injected with meth (1 mg/kg, i.p.) caused mRNA expression that was 
significantly less that mRNA expression resulting from meth with the vehicle (**p<0.01). Data are 
mean s.e.m., n=3-5/group. (Northcutt et. al., in preparation).  
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Discussion 
 The present studies further support the role of TLR4 mediated proinflammatory signaling 
in cocaine reward, as well as highlight how it may contribute to reinforcement. Cocaine 
stimulates microglia cells through a TLR4 dependent mechanism, a consequence of which is the 
upregulation of IL-1β mRNA that is highly specific to the VTA. Cocaine-induced TLR4 
activation is crucial for establishing cocaine CPP, while intra-VTA TLR4 activation and IL-1β 
signaling are necessary for the cocaine-induced NAc dopamine increase. Furthermore, repeated 
cocaine exposure exhibits a TLR4 mediated glial priming effect, which is necessary for 
reinstatement to cocaine seeking. These findings are consistent with the recently proposed 
xenobiotic hypothesis of drug abuse: TLR4, within the innate immune system of the CNS, 
identifies addictive drugs such as cocaine as foreign invaders, much like it does for pathogens, 
and initiates proinflammatory signaling as a response that has downstream effects on the 
mesolimbic dopamine pathway (Hutchinson & Watkins, 2014). This model already has a great 
deal of support in regard to morphine: morphine-induced TLR4 mediated signaling results in the 
expression of nueroinflammatory markers, counteracting its analgesic effects while resulting in 
drug reward (Watkins et. al., 2007; Hutchinson et al., 2012) 
 The xenobiotic hypothesis is not only supported by the findings presented here and in our 
recent publications (Hutchinson et al., 2012; Hutchinson & Watkins, 2014; Northcutt et al., 
2015) but is also supported by existing literature. For example, one study compared the response 
to reinstatement of cocaine to other DAT antagonists in a self-administration (S-A) and 
reinstatement paradigm in order to measure the reinforcing effects of the drugs. It was found that 
other DAT antagonists, such as benztropine analogs, that cause NAc dopamine increases do not 
instigate significant responding to reinstatement, signifying low abuse liability (Hiranita et. al., 
2009). The authors later examined both slow and fast acting benztropine analogs and found that 
neither caused significant conditioned-place preference, a well-supported behavioral measure of 
drug reward (Li et. al., 2011). It may be that the DAT antagonists did not share the second 
mechanism of activating TLR4 and thus did not elicit the same level of reinstatement to cocaine 
seeking or rewarding effects in CPP paradigms.  
 The proinflammatory response to cocaine appears to be an important component 
underlying disruptions to the mesolimbic pathway that contribute to drug reward and 
reinforcement.  Although it is currently unknown exactly how proinflammatory signaling 
influences the mesolimbic pathway, it has been shown that proinflammatory cytokines are 
neuroexcitatory. IL-1β, IL-6, and TNFα are now known to be powerful modulators of neuronal 
excitability (Vezzani & Viviani, 2014). These cytokines can act directly on neurons via 
specialized receptors to control excitability (Schwarz et. al., 2013). For example, TNFα 
modulates receptor trafficking, increasing surface AMPA receptor density while decreasing 
surface GABA receptor density, thus making synapses more excitatory (Stellwagen et. al., 2005). 
IL-1β can bind IL-1 receptors expressed on dopaminergic neurons causing enhanced 
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conductivity of NMDA receptors, highlighting its importance in the mesolimbic dopamine 
circuit (Ho & Blum, 1998; Viviani et. al., 2003).  
Repeated use of meth, and to a lesser extent, cocaine, is associated with neurotoxicity 
wherein, through fairly uncharacterized mechanisms, there is damage to the blood-brain barrier 
and neurons (Sharma et. al., 2014). LPS induced IL-1β signaling can contribute to dopaminergic 
neuronal cell death, indicating that the cytokine may play a role in excitotoxicity (excessive 
neuron stimulation leading to cell damage or death) (Godoy et. al., 2008; Long-Smith et. al., 
2010). Two to three hours preceding excitotoxic cell death, the chemokine fractalkine is rapidly 
cleaved from neuron cell membranes so the now soluble chemokine can promote chemotaxis (or 
migration in response to chemical stimulus) of microglia (Chapman et. al., 2000), where it is 
now free to bind its receptor CX3CR1. IL-6 induces expression of this fractalkine receptor on 
microglia (Lee et. al., 2010) and when bound by fractalkine, CX3R1 activation causes the release 
of IL-1β (Clark et. al., 2015). Evidentially, proinflammatory signals may self-amplify, resulting 
in greater effects on the mesolimbic dopamine pathway. Interestingly, it was found here that only 
with repeated administration of cocaine were IL6 mRNA levels upregulated while a single 
injection of meth was sufficient to upregulate IL6 mRNA.  Much remains to be discovered about 
the complicated cytokine IL-6; however this finding may be relevant to understanding the 
mechanisms underlying the neurotoxic consequences of psychostimulant use. 
 In this investigation, it was demonstrated that microglia display a proinflammatory 
immune response to TLR4 activation by cocaine. This was assessed by isolating whole-brain 
microglia, treating them in culture with the drug of interest for 24 hours, and quantifying mRNA 
levels using qRT-PCR. When cultured with varying concentrations of cocaine, microglia 
concentration-dependently upregulate IL-1β mRNA. When cultured with 1 and 10 ng/mL doses 
of LPS serving as the positive control, IL-1β mRNA expression was significantly upregulated 
indicating that the cultured microglia were in good health and fully functional. In cultured 
neonatal microglia, it was demonstrated that cocaine’s effect on microglial IL-1β mRNA 
expression is TLR4 mediated because cocaine-induced mRNA upregulation could be suppressed 
with (+)-naloxone (Northcutt et. al., 2015; Sup. Figure 1). These data validated the role of 
microglia in expressing IL-1β in response to cocaine, yet the role of astrocytes should not be 
overlooked in future studies as they display proinflammatory and neuroexcitatory activity in 
response to microglial activation (Pascual et. al., 2012). 
 A single systemic injection of cocaine induced expression of IL-1β mRNA in the 
mesolimbic dopamine pathway, specifically in the VTA. Real time qRT-PCR analysis of tissue 
samples collected from the PFC, NAc, and VTA following acute cocaine administration enabled 
for regional specificity when examining the cocaine-induced proinflammatory response. The 
VTA sends dopaminergic projections to the NAc, so the finding that cocaine-induced IL-1β 
mRNA upregulation in the VTA likely has substantial impact on the mesolimbic dopamine 
pathway. As noted previously, IL-1β is able to bind IL-1 receptors on dopaminergic neurons and 
make them more prone to excitation (Ho & Blum, 1998; Viviani et. al., 2003). Therefore, this 
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may explain how the IL-1 receptor antagonist (IL-1ra) injected directly into the VTA could 
inhibit extracellular dopamine increases in the NAc following systemic administration of 
cocaine. This finding, along with other findings represented in supplementary figure 3, indicates 
that TLR4 signaling in the VTA is necessary for cocaine to produced elevations of dopamine in 
the NAc.  However, direct activation of TLR4 signaling in the VTA with a microinjection of 
LPS alone does not increase dopamine signaling to the same extent that cocaine does (200% 
increase by LPS versus 300% increase by cocaine). This implies that both DAT antagonism and 
TLR4 agonism by cocaine might be necessary to cause such a large dopamine increase in the 
NAc. 
 Behavioral data from cocaine CPP has shown that cocaine-induced TLR4 signaling is 
necessary for reward (Northcutt et. al., 2015), but how it may be involved in addiction-like 
behaviors was previously unknown. Recent findings indicate that TLR4 activation is necessary 
and sufficient for reinstatement to cocaine seeking (Sup. Figure 4). Drug reinforcement was 
measured using a self-administration and reinstatement paradigm which revealed that 
reinstatement to cocaine seeking is attenuated by intra-VTA IL-1ra pretreatment to the cocaine 
challenge (Sup. Figure 5). However, intra-VTA blockade of IL-1β signaling did not fully 
suppress reinstatement to cocaine seeking as it did with systemic TLR4 antagonism using (+)-
naltrexone (Bachtell et. al., unpublished). This implies that while cocaine reward may initially be 
mediated predominately by IL-1β, cocaine reinstatement may be mediated by other TLR4 
dependent signaling molecules.  
 To explore this possibility, the mRNA expression of a several proinflammatory markers 
in response to a cocaine challenge following cocaine self-administration (S-A) and extinction 
was measured in the mesolimbic dopamine pathway. First, a timecourse study was conducted 
comparing mRNA expression at 30 minutes and 2 hours following the cocaine reinstatement 
challenge. IL-1β mRNA was significantly upregulated in the VTA at 2 hours following the 
cocaine prime in cocaine S-A animals, displaying a more exaggerated upregulation than what 
was observed in response to an acute cocaine injection in naïve animals. This 2 hour timepoint 
was utilized in the following study designed to explore this enhanced mRNA response observed 
in cocaine S-A animals. The follow-up two-by-two study compared the effects of saline self-
administration versus cocaine self-administration as well as the effects of a saline versus cocaine 
reinstatement challenge on expression of neuroinflammatory markers within the mesolimbic 
dopamine pathway. The first comparison could show how chronic cocaine self-administration 
may alter the expression of neuroinflammatory markers in contrast to absent and acute cocaine 
administration. Adding groups that received a cocaine challenge allowed further observation of 
the proinflammatory response to an acute cocaine administration (in the saline self-
administrating rats) as well as the investigation into a potential microglia priming effect (in 
cocaine self-administering rats). 
 Microglial priming is a well-supported yet poorly understood phenomenon that was first 
characterized in peripheral macrophages in what was termed the Schwartzman reaction 
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(Schwartzman, 1928); wherein acute immune system activation leads to immune system 
sensitization resulting in an exaggerated response to subsequent activation. The phenomenon was 
first observed on microglia in the CNS in the aged or diseased brain (Perry, Cunningham & 
Holmes, 2007; Dilger & Johnson, 2008; Streit & Xue, 2009) and was termed microglia 
“priming” by Perry, Cunningham & Holmes. It was found that microglia, in the aged or diseased 
brain, enter a primed state where they are sensitized to subsequent activation resulting in a more 
robust proinflammatory response and further microglial activation (Perry, Cunningham & 
Holmes, 2007; Roca et. al., 2011; Boche, Perry, & Nicoll, 2013). In a primed state, microglia 
upregulate IL-1β mRNA expression and then secrete large amounts of the cytokine when 
activated (Perry, Cunningham & Holmes, 2007; Roca et. al., 2011). Whether or not microglia 
will become primed by a stimulus depends on what the stimulus is. Different doses of LPS, 
varying degrees of tissue injury, different proinflammatory cytokines, excitotoxicity, and various 
diseases can all activate microglia cells in different ways, resulting in varied responses that may 
have beneficial or harmful, neurotoxic effects. It has been shown that primed microglia in a 
Parkinson ’s disease model of neurodegeneration are responsible for upregulated IL-1β mRNA, 
and a more robust IL-1β release following an LPS challenge, thus facilitating further 
neurodegeneration (Godoy et. al., 2008; Roca et. al., 2011). A high dose of LPS will actually 
result in a suppressed proinflammatory response from microglia cells by increasing RelB 
(proinflammatory transcription repressor) binding to NFKB, (proinflammatory transcription 
factor) (Schaafsma et. al., 2015). However, an extremely low dose of LPS results in the removal 
of RelB via interleukin receptor-associated kinase 1 and Toll-interacting protein-dependent 
mechanisms; a genetic alteration that results in a more proinflammatory microglia phenotype, 
e.i., primed microglia (Deng et. al., 2013; Morris et. al., 2014). It is evident that differential 
activation of microglia, especially through TLR4, can result in a variety of responses, including 
priming. Therefore, it is possible that cocaine interacts with the TLR4/MD-2 complex in such a 
way that leads to a priming signaling cascade. If so, this phenomenon could account for chronic 
cocaine-induced neurotoxicity and the robust proinflammatory response described above.  
  Evidence for glial priming may be evident in findings presented in Experiment 5; 
chronic cocaine self-administration caused an extremely significant upregulation of IL-1β 
mRNA within the vmPFC that, when compared to the saline S-A group, was not observed in 
response to acute cocaine administration. NFKB mRNA was also upregulated after chronic 
cocaine S-A and the cocaine challenge, perhaps indicating that repeated cocaine administration 
primed microglia, causing sustained changes in gene expression leading to IL-1β mRNA 
upregulation in this region. Perhaps this robust proinflammatory response plays an indirect role 
in facilitating changes in behaviors like impulsivity and low self-control associated with altered 
prefrontal cortex activity in the cocaine addict that are thought to contribute to relapse and/or 
continued cocaine use (Goldstein & Volkow, 2005; Winstanley et al., 2009). Whether IL-1β 
signaling in the vmPFC serves to drive these behavioral changes remains to be explored and 
appears to be a worthy target for further research.  
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 Both the cocaine challenge and cocaine self-administration in general prompted a 
significant IL-1β mRNA upregulation in the NAc. One could hypothesize that this is due, in part, 
to the cocaine-induced dopamine increase in the NAc because microglia have been shown to 
directly respond to the release of dopamine in this region (Schwarz et. al., 2013). This suggests 
that some of the proinflammatory response to cocaine in the mesolimbic dopamine pathway may 
be due to cocaine’s neuronal actions indirectly, in addition to its direct action on TLR4. There 
may also be evidence of microglial priming as there is a robust, 450% upregulation of IL-1β 
mRNA in cocaine self-administering rats following subsequent cocaine administration 
(reinstatement challenge). One limitation of examining IL-1β in the NAc, however, involves the 
highly variable IL-1β mRNA response to cocaine administration. Previous work from this lab 
has shown mRNA expression of this cytokine to be somewhat inconsistent in response to acute 
cocaine within the NAc (Northcutt et al., 2015). One possible explanation is that the time during 
which the IL-1β gene is being transcribed varies slightly, and the 2 hour timepoint used captures 
the mRNA expression at the beginning, middle, or end of a wave. Further studies could 
incorporate additional timepoints to investigate the cause of this phenomenon.  
 The VTA remained the site of the most extensive proinflammatory response. Here, 
chronic cocaine self-administration upregulated mRNA expression of IL-1β, IL-6, NFκB, and 
GFAP when compared to the saline S-A group. These data demonstrate that repeated cocaine 
exposure activate glia to drive additional proinflammatory processes not observed with a single 
dose of cocaine. GFAP mRNA upregulation would indicate that astrocytes are now activated, 
responding to inflammation and possibly cell damage. As discussed previously, IL6 mRNA is 
only upregulated in this chronic cocaine exposure paradigm. The upregulation of these mRNAs 
in addition to IL-1β may reflect the neurotoxic effects of chronic cocaine exposure (Sharma et. 
al., 2014). Upregulation of NFκB expression could indicate that cells are attempting to further 
strengthen the immune response to “fight off” the chronic foreign invader, in this case, cocaine. 
Furthermore, chronic cocaine administration appears to sensitize glia such that subsequent 
cocaine administration significantly upregulates mRNA expression of IL-6, CD11B (the 
microglia activation marker), and possibly IL-1β (nearly significant) when compared to cocaine 
self-administering animals that did not receive a cocaine reinstatement challenge. Together, this 
data provides evidence as to how cocaine may prime glia to employ a prolonged and exaggerated 
neuroinflammatory response, which may underlie processes contributing to cocaine 
reinforcement and relapse.  
Current work aims to further explore microglial priming by utilizing IHC staining for 
CD11B and MD-2 in the mesolimbic dopamine pathway in the brains of cocaine self-
administering rats. Comparing the densities of CD11B and MD-2 between regions and between 
cocaine versus saline self-administering rats will provide insight into why the VTA displays a 
robust immune response to acute and especially chronic cocaine administration. It will also 
reveal if chronic cocaine administration causes enhanced chemotaxis and activation of microglia, 
effectively priming them to be more responsive to cocaine within the mesolimbic dopamine 
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pathway. Additionally, this experiment will help identify what cell types within the mesolimbic 
dopamine pathway express MD2.  Although the TLR4-MD2 complex is predominately located 
on microglial cells throughout the brain, there are specific instances where TLR4 has been 
described on sensory neurons (Diogenes et. al., 2011).  Although it is expected that TLR4-MD 
complexes will also be expressed on microglia, the results of this study and related follow-up 
studies should be informative. Figure 8 depicts preliminary CD11B staining in the NAc of one 
naïve (Figure 8a) and one cocaine S-A (Figure 8b) rat. The microglia in these pictures can be 
qualitatively evaluated using the microglial activation classification of Kreutzberg (1996). 
Microglia from naïve rats appear to be in Stage 1 (resting, or quiescent, microglia having a small 
cell soma and highly ramified processes). Activated microglia retract their processes and have a 
larger cell soma and thicker processes (Kettenmann et. al., 2011). Cocaine S-A microglia appear 
to be mostly in Stage 3 (amoeboid microglia: round shaped body with short, thick and stout 
processes) with some in Stage 2 (activated ramified microglia: elongated shaped cell body with 
long and thicker processes). It cannot be concluded from morphology alone that microglia in 
Stage 3 are primed and not just activated (Perry, Cunningham & Holmes, 2007); however, 
primed microglia upregulate IL-1β mRNA expression (as observed in Experiment 5) and do so 
primarily in Stage 3 (Perry, Cunningham & Holmes, 2007; Boche, Perry, & Nicoll, 2013), which 
was observed in the cocaine S-A rat NAc. Upon subsequent activation, primed microglia enter 
Stage 4 (phagocytic cells: round shaped cells with vacuolated cytoplasm, no processes can be 
observed at light microscopy level) and secrete larger amounts of IL-1β than their unprimed 
counterparts (Boche, Perry, & Nicoll, 2013). This experiment will evidently unveil clues of 
cocaine-induced microglial priming as well as cocaine reactivity, while a future IHC experiment 
could include a cocaine S-A group that received a cocaine reinstatement challenge to see if there 
are any Stage 4 microglia present.  
 Another approach will soon be taken to further investigate microglia priming in response 
to chronic cocaine exposure. Rapidly isolating microglia from a cocaine S-A rat at the end of S-
A and after extinction would allow microglia cells specifically to be tested for exaggerated, or 
primed, inflammatory responses to various treatments. Along with appropriate positive and 
negative controls, these cells will be treated in culture with cocaine/saline in media or with 
cocaine/(+)-naloxone in media. This would reveal if microglia themselves display primed 
activity following repeated cocaine S-A, and if they remain primed through extinction where 
intense cravings begin to emerge. If they do indeed display an enhanced proinflammatory 
response to cocaine treatment, (+)-naloxone in conjunction with cocaine treatment will confirm 
if the effect is TLR4 dependent and can be suppressed in vitro.  
 A limitation of the qRT-PCR study on the two-by-two saline and cocaine self-
administration study (Experiment 5) was that rats were given their reinstatement challenge in 
their home cages; the significance of which being that they were not exposed to the cocaine 
associated cues (placement in self-administration apparatus box or the available lever to press). 
The presentation of a drug cue is a crucial part of why both rats and humans relapse into cocaine 
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use (Lu et. al., 2004). Adding a cocaine self-administering group that is exposed to cocaine-
paired cues prior to receiving the reinstatement challenge would provide insight into how drug-
paired cues may influence neuroinflammation within the mesolimbic dopamine pathway. The 
proinflammatory effects of cocaine reinstatement paired with the drug cue and without it may 
prove to be additive within the NAc (Fuchs et. al., 2004). In examining this possibility, it would 
be important to examine the proinflammatory response within the NAc core, as there is evidence 
that cue-induced cocaine reinstatement is driven by the NAc core rather than the shell (Fuchs et. 
al., 2004; Welberg, 2013).  
 The xenobiotic hypothesis likely also applies to meth, as it is shown to interact with the 
TLR4/MD-2 complex (Northcutt et. al., in preparation). It has been demonstrated that TLR4 
blockade by (+)-naloxone inhibits meth-induced CPP (Sup. Figure 6). Additionally, meth-
induced dopamine increases in the NAc can be attenuated by (+)-naloxone (15 mg/kg, i.p.) 
(Northcutt et. al., in preparation; Sup. Figure 7).  In contrast to findings where (+)-naloxone 
completely suppressed cocaine-induced NAc dopamine elevations, (+)-naloxone demonstrates a 
partial attenuation. This is likely due to the fact that much of this dopamine increase could be 
attributed to meth’s reversal of the dopamine transporter (DAT) and interference with the 
vesicular monoamine transporter-2 (VMAT-2), resulting in more free dopamine in the axon 
terminal that may now flow out of DATs. However, TLR4 signaling still appears to result in 
approximately half of the meth-induced NAc dopamine increase. Other differences should be 
noted between cocaine and meth findings discussed here; notably, IL-1β mRNA expression is 
not upregulated in response to an acute meth administration in the PFC, NAc, nor, and most 
importantly, in the VTA. However, upregulation of CD11b, GFAP, IL6, and TNFα was 
suppressed with systemic (+)-naloxone, indicating that meth-induced neuroinflammation is 
TLR4-dependent. This implies that other TLR4 mediated signaling may be responsible for 
contributing to the rewarding effects of meth. In fact, mRNA for IL-6, along with GFAP, is 
expressed in response to acute meth. Note that IL-6 and GFAP mRNA were only upregulated in 
the VTA in response to cocaine in a chronic, self-administration model (Figure 5). Because meth 
is highly neurotoxic, while cocaine neurotoxicity is only evident with more chronic exposure 
(Sharma et. al., 2014), IL-6 and GFAP may be causal to, or indicative of, this neurotoxicity. 
Meanwhile, TLR4 blockade could completely suppress cocaine-induced reinstatement; while 
intra-VTA IL-1ra could only attenuate it (Sup. Figures 4,5).  If IL-1β signaling alone cannot take 
full credit for reinforcement of cocaine, and seemingly is not involved in TLR4 mediated meth 
reward, then some other TLR4 dependent mechanisms must be involved. These mechanisms 
may relate to processes underlying neurotoxicity, as chronic cocaine exposure and acute meth 
exposure both display neurotoxicity as well as share IL-6 and GFAP mRNA upregulation. 
Additionally, acute meth exposure leads to the upregulation of TNFα mRNA. As these proteins 
respond to neurotoxic events, possibly leading to additional microglial activation (Vilhardt, 
2005), they may play a large role in NAc dopamine signaling. For instance, IL-6 has been shown 
to lead to IL-1β release from microglia through an excitotoxicity-sensitive mechanism requiring 
the initiation of CX3C1 receptor expression; a process that could contribute to robust and 
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prolonged meth-induced NAc dopamine increases. It is possible that IL-6 has a delayed response 
in mediating dopamine release that is highly reactive to acute meth administration, but only 
reactive to chronic cocaine administration. This is suggestive of a highly involved role of IL-6 
within the mesolimbic dopamine pathway. Future experiments will explore the effects of intra-
VTA IL-6 antibodies on meth-induced NAc dopamine increase. If the treatment proves 
successful in inhibiting this NAc dopamine increase, it should then be tested in a cocaine self-
administration and reinstatement experiment.   
 Together, the data presented in this thesis further the understanding that drugs of abuse, 
especially the psychostimulants cocaine and meth, must be examined in regards to both their 
neuronal and neuroimmune actions within the brain. Cocaine reward and reinforcement may 
require both the antagonism of dopamine transporters on neurons and the agonism of TLR4. This 
research explored how neuroinflammation contributes to cocaine reward, reinforcement and 
relapse. The collaboration that allowed for study of cocaine-primed reinstatement allowed for 
cocaine-induced neuroinflammation to be studied in a clinically relevant model of relapse to 
cocaine use. This provided insight into how the brain’s immune system might respond to 
repeated cocaine use in an addict. Current evidence suggests that Perry, Cunningham, & Holmes’ 
(2007) glial priming phenomenon could be combined with Hutchinson & Watkin’s (2014) 
xenobiotic hypothesis of TLR4 mediated drug reward to include reinforcement as follows: (1) 
TLR4 within the innate immune system recognizes addictive drugs, such as cocaine, as foreign 
invaders and initiates glial proinflammatory cascades; (2) drug-induced proinflammatory 
signaling can drive acute drug reward; (3) proinflammatory signaling can be amplified by 
repeated drug exposure that primes glial activation resulting in an over-exaggerated 
inflammatory response; (4) this effect may prolong and enhance chronic drug-induced 
neuroinflammation that may drive drug reinforcement; (5) these rewarding and reinforcing 
effects are the result of downstream proinflammatory signaling on the mesolimbic dopamine 
pathway. Further investigation, in a self-administration and reinstatement model, into cocaine-
induced glial priming, meth-induced neuroinflammation, psychostimulant neurotoxicity, and 
psychostimulant-responsive cytokines such as IL-1β and IL-6, may lead to the characterization 
of an effective pharmacological intervention (such as (+)-naloxone) for psychostimulant 
addiction that could regulate proinflammatory cascades to possibly halt the reinforcing actions of 
these drugs or reduce drug craving during recovery.  
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Supplemental Figures  
 
Sup. Figure 1: Cocaine-induced signaling in islolated neonatal microglial cells is Toll-like receptor 4 
(TLR4) dependent. (a) Lipopolysaccharide (LPS) dose-dependently upregulated mRNA expression of 
interleukin-1beta (IL-1β; ***p<0.01 and ****p<0.001, Bonferroni post hoc) in neonatal migroglia 
following 1h incubation (one-way analysis of variance (ANOVA), F(5, 23)=62.29, p<0.003). (b) Cocaine 
(0.1 and 1 μM) upregulates mRNA expression of IL-1β (**p<0.01, Bonferroni post hoc) in neonatal 
micgroglia following 1h incubation (one-way ANOVA, F(4, 19)=11.56, p=0.0002). (c) (+)-naloxone (1, 10, 
and 100 μM) suppresses cocaine-induced upregulation of IL-1β mRNA (p<0.0001; two-way ANOVA, 
interaction F(6, 33)=19.68, p<0.0001, Bonferroni post hocs). Incubation with (+)-naloxone alone had no 
effect on IL-1β mRNA expression (p>0.05). (Northcutt el. al., 2015; reprinted with permission).  
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Sup. Figure 2: (+)-Naloxone suppresses cocaine-induced upregulation of interleukin-1beta (IL-1β) 
mRNA in the ventral tegmental area (VTA) (b) Cocaine-induced (10 mg/kg, i.p.) upregulation compared 
with saline (p=0.01) of IL-1β mRNA within the VTA 30 minutes following injection is attenuated by (+)-
naloxone (2.5 mg/kig given in two subcutaneous (s.c.) injections, the first given 10 minutes before the 
second, which is paired with cocaine) administration (*p<0.05). Bonferroni post hocs were preceded by 
two-way ANOVA, indicating the main effects of cocaine (F(1, 17)=4.61, p=0.0001) and (+)-naloxone (F(1, 
17)=4.61, p=0.0447). Data are mean s.e.m., n=5-6/group. (c) Cocaine-induced (10 mg/kg, i.p.) 
upregulation compared with saline (**p<0.01) of IL-1β mRNA within the VTA 30 minutes following 
injection is attenuated by (+)-naloxone (2.5 mg/kig given in two subcutaneous (s.c.) injections, the first 
given 10 minutes before the second, which is paired with cocaine) administration (p<0.01). Bonferroni 
post hocs were preceded by two-way ANOVA, indicating the main effects of cocaine (F(1, 16)=5.18, 
p=0.03) and (+)-naloxone (F(1, 16)=16.12, p=0.001). Data are mean s.e.m., n=5-6/group. (Northcutt et. al., 
2015; reprinted with permission).  
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Sup. Figure 3: Cocaine-induced increases of nucleus accumbens (NAc) dopamine are dependent on Toll-
like receptor 4 (TLR4) signaling within the ventral tegmental area (VTA). (a) Cocaine (10 mg/kg, 
subcutaneous (s.c.)) produces elevated extracellular dopamine in the NAc 40 min (****p<0.0001) and 60 
min (*p<0.01) following drug administration (repeated measures two-way analysis of variance (ANOVA) 
with Bonferroni post hocs, time and treatment interaction p<0.001). Administration of (+)-naloxone (2.5 
mg/kg in two s.c. injections spaced 10 min apart) blocked this effect; there were no differences between 
this group and the saline or (+)-naloxone-treated rats. Before drug treatment, there were no differences in 
extracellular dopamine concentrations in the NAc shell across all groups. Data are mean s.e.m., 
n=4/group. (b) Cocaine (10 mg/kg, intraperitoneal (i.p.)) produces elevated extracellular dopamine in the 
NAc that sustains for 40-100 min (Bonferroni, *p<0.05, **p<0.01 and ****p<0.0001) following drug 
administration. Intra-VTA LPS-RS (lipopolysaccharide, a TLR4 antagonist naturally produced by 
Rhodobacter sphaeroides) blocked this effect. There were no differences between other treatment groups. 
Data are mean s.e.m., n=4/group. (c) LPS (10 ng in 1 μL) microinjected into the VTA produces 
increased extracellular dopamine within the NAc compared with vehicle microinjection controls (two-
way ANOVA, effect of treatment F(1, 144)=35.83, p<0.0001 and time F(11, 144)=2.89, p=0.0018) 40 and 100 
min after microinjection (*p<0.05, Bonferroni post hoc). Data are mean s.e.m., n=5-7/group. (Northcutt 
et. al., 2015; reprinted with permission).  
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Sup. Figure 4: Toll-like receptor 4 (TLR4) blockade dose-dependently suppresses reinstatement to 
cocaine seeking. Rats self-administered saline or cocaine (0.5 mg/kg/infusion) on a fixed ratio 1 schedule 
of reinforcement in 15 daily sessions. Lever responding was extinguished in 8 daily extinction sessions. 
Reinstatement testing consisted of two phases. The first was a 2 hr extinction phase immediately followed 
by a 2 hr reinstatement phase. (+)-Naltrexone (3.75, 7.5, 15 mg/kg) was administered as a pretreatment to 
a cocaine prime (15 mg/kg, ip).  (* p < 0.05). (Bachtell et. al., unpublished).  
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Sup. Figure 5: Interleukin-1 receptor antagonist (IL-1ra) injected into the ventral tegmental area (VTA) 
attenuates reinstatement to cocaine seeking. Rats, with surgically implanted bilateral injection guide 
cannula aimed at the VTA, self-administered saline or cocaine (0.5 mg/kg/infusion) on a fixed ratio 1 
schedule of reinforcement in 15 daily sessions. Lever responding was extinguished in 8 daily extinction 
sessions. Reinstatement testing consisted of two phases. The first was a 2 hr extinction phase immediately 
followed by a 2 hr reinstatement phase. IL1ra was microinjected into the VTA (10 µg/side) as a 
pretreatment to a cocaine prime (15 mg/kg, ip).  (*** p < 0.001). (Bachtell et. al., unpublished).  
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Sup. Figure 6: TLR4 signaling is necessary for meth-induced conditioned-place preference (CPP). Two-
way analysis of variance (ANOVA) revealed a significant effect of meth (****p<0.0001) and (+)-
naloxone (*p<0.05) while bonferroni post hocs revealed a significant effect of (+)-naloxone suppressing 
preference within the meth group (**p<0.01). Data are mean s.e.m., n=5-6/group. (Northcutt et. al., in 
preparation). 
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Sup. Figure 7: Large meth-induced increases in nucleus accumbens (NAc) dopamine rely on TLR4 
signaling. There is a significant effect of time and treatment (****p<0.0001) as well as a significant 
interaction (****p<0.0001) (two-way analysis of variance (ANOVA)). Meth (1mg/kg, i.p.) with vehicle 
causes significant dopamine increases at 40, 60, 80 min (****p<0.0001), at 100 min (***p<0.001), and 
120 min (*p<0.05) (Bonferroni post hocs). (+)-naloxone (15 mg/kg, i.p.) with meth (1 mg/kg, i.p.) 
suppressed the meth-induced dopamine increase at 40 min (**p<0.01). The (+)-naloxone (15 mg/kg, i.p.) 
with meth (1 mg/kg, i.p.) group displayed significantly more dopamine than the saline/saline control at 
100 min (**p<0.01) and 120 min (*p<0.05) (Bonferroni post hocs). Data are mean s.e.m., n=3-5/group. 
(Northcutt et. al., in preparation).  
 
 
 
 
